"Great ideas are those of which the only thing that surprises us is that we not occurred before"

Promoting Scientific Research

In recent decades, biotechnology and regenerative medicine have seen some highly significant progress. This is due, at least in part, to the immense efforts made by the scientific community to really come to grips with the basic fundamentals of cell biology and to apply technological knowledge with a view to improving diagnosis, rehabilitation, and tissue regeneration. Accepting these postulates, scientists dream of the day when they will be able to correct or repair damaged tissues or even develop new tissues and organs, which would, without doubt, prove a landmark in the treatment of a great many physiopathological conditions and chronic diseases.

The success of the Endoret® (PRGF®) technique is due to an intensive study of the latest advances in research into the basic biological and molecular principles behind the mechanisms of repair and regeneration. This technique was the first to be described in the world literature as a means of obtaining 100% autologous plasma, thus circumventing the problems of biosafety that other techniques present. Moreover, the preparation can be produced from a small volume of blood, depending on the size of the lesion to be treated. Another extremely important consideration when calculating the social and health impact of the procedure is that obtaining Endoret® (PRGF®) is highly cost-effective.

One aspect of Endoret® (PRGF®) that really stands out is that from a single quantity of patient’s blood it is possible to obtain different biological and biomedical products offering the possibility of exploring a considerable number of therapeutic applications.